Trial Profile
Study comparing fesoterodine and tolterodine in younger and older women with overactive bladder: A pooled analysis of 2 placebo-controlled trials
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 23 Feb 2011
Price :
$35
*
At a glance
- Drugs Fesoterodine (Primary) ; Tolterodine
- Indications Overactive bladder
- Focus Therapeutic Use
- Sponsors Pfizer
- 23 Feb 2011 New trial record